Moleculin Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
MBRX Key Statistics
Stock Snapshot
Moleculin Biotech(MBRX) stock is priced at $2.30, giving the company a market capitalization of 12.59M. It carries a P/E multiple of -0.07.
As of 2026-05-19, Moleculin Biotech(MBRX) stock has fluctuated between $2.04 and $2.39. The current price stands at $2.30, placing the stock +12.9% above today's low and -3.6% off the high.
Moleculin Biotech(MBRX) shares are trading with a volume of 272.61K, against a daily average of 290.27K.
During the past year, Moleculin Biotech(MBRX) stock moved between $1.79 at its lowest and $25.00 at its peak.
During the past year, Moleculin Biotech(MBRX) stock moved between $1.79 at its lowest and $25.00 at its peak.
MBRX News
• Moleculin Biotech shares are retreating from recent levels. What’s behind MBRX decline? The MIRACLE study is comparing two dosing arms of Annamycin plus cytar...
Moleculin Biotech (MBRX) announced it is approaching the first unblinding of data from its pivotal Phase 2B/3 “MIRACLE” trial evaluating Annamycin in combinatio...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
More MBRX News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.